As this study examined the effect of FGF1-PIGN on ISOS-1 cells in vitro, future in vivo analysis using angiosarcoma model mice is required to determine effective FGF1-PIGN dosages for the treatment of angiosarcoma. This evidence concerns the gene FGF1 and angiosarcoma.